Literature DB >> 7275226

Newcastle disease virus antibodies in human sera.

S Charan, V M Mahajan, L P Agarwal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7275226

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  5 in total

1.  Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.

Authors:  Gayathri Vijayakumar; Stephen McCroskery; Peter Palese
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

Review 2.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

3.  Recombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry.

Authors:  Zhiyuan Wen; Bolin Zhao; Kun Song; Xule Hu; Weiye Chen; Dongni Kong; Jinying Ge; Zhigao Bu
Journal:  Virol J       Date:  2013-11-09       Impact factor: 4.099

Review 4.  Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer.

Authors:  Volker Schirrmacher; Philippe Fournier
Journal:  Methods Mol Biol       Date:  2009

5.  Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.

Authors:  Ying An; Tianyan Liu; Jinjiao He; Hongsong Wu; Rui Chen; Yunye Liu; Yunzhou Wu; Yin Bai; Xiaochen Guo; Qi Zheng; Chang Liu; Jiechao Yin; Deshan Li; Guiping Ren
Journal:  J Biomed Sci       Date:  2016-07-28       Impact factor: 8.410
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.